Endgame with Gita Wirjawan - Potensi Tanpa Aktualisasi Buat Apa? | #Endgame ft. Nadhira Afifa (Part 3)

Episode Date: September 27, 2020

Dari dulu kita sering disebut sebagai negara yang memiliki banyak potensi. Kini sudah saatnya kita beraktualisasi agar potensi tersebut berbuah daya saing dan kesejahteraan, dimulai dari lebih banyak kepemimpinan manajerial di lingkup kebijakan kesehatan dan pemaksimalan talenta R&D (Penelitian dan Pengembangan) lewat fasilitas dan anggaran yang lebih memadai.

That's like, like, it's going to beaughan really get-tinkalant, like, from the same of the SMs, I'm like, like, a country that's going to but,

but it's the from the security to, like, like, countries in Africa, and the that's the

that I was to be able to if I was being, I'm going to be done. Yeah, ma. This is end game.

Okay, we talk about about We'll talk about about it. We'll be what? How about it, 10, or up to 25 years? 25, maybe. Oh, 15, yeah, sir, pa. Okay. You're going to be 18 years.

Forty-year-old. Yeah, right? You've been married, the life of the kids? No. Okay. Where do you see yourself when you're 40? 40. In the same 2005?

In 2005, I must have hopefully, the ATT company's already in South Asia, maybe. Amen. Oh, so it's regional, yeah? Regional, but not local, yeah. Yeah, aiming's going to, ma'am. Okay, okay.

Then, it's been doctor, specialist, Anna. Okay. Oh, yeah. So, yeah. So, yeah. Okay. Possible?

Nothing is impossible. Yeah, amen. And then what? Mentiary P.U. I'm not. I'm not. Or Mentiary Healthan, ma'am. Mentional, maybe,

all of many, like, MENTRIMENTY-MENTY-Qaeda. So, the passion is still in the CASEATO. But I think it's going to be with the power of technology. Yeah, it's like that, like,

MENTRIPENDICAN, like, before-sellulmnsi, from academici, from rector or decan. It's always conventional, but now with Adim, actually, it's more than it's more than it's more than technology, that's what we need technology.

It's a lot. But what other? What else? Is it more? It's more, it's more. It's very, thanky, big, big, very. Menter Kesthetan.

On your first day, as a minister, what would you do? On your first day, from the first day, okay in the first month. In the first month. Or first year? What? Deliverables? Oh, do you know, manned minister,

like, like, in interview, but I'm asking you, don't ask me. First, maybe, first month just, yeah, just, just, can't, you start it out with an imagination. Yeah, right, okay, for imagination. Right, right. Maybe, maybe,

I think of coordination first, if I'm not only for the world of the health, I think of the United States, there's a lot of the United States, there's a lot of Indonesia, and, and, sometimes, vis-imisiness not as a-jalan, not the way, but the reason is not justa-gallant,

but the two-oenna, and in slas-sla-sle-it-justro, justro, there just to be a problem, but the main-ut-ut-ut-ut-ut-ut-ut-ut-ut-math. Maybe it's more than the between the end of the end of the same, to maximize the impact, now, I want to try it a little,

if in some of the other than in the country, no, no, it's not even to be it's not a doctor. Right, yeah. Singapore, yeah. Well, I didn't want to mention. And, you're going to co-orinacy. You're a little to get into about our attention to the

for the other than the other than medical know-how. Right, right? What I like is, is that you peck-as-kka-as-kali with the elmue management. Yeah, right? Right now, I'm going to beaure policy and so again. How do you think of it? I mean, do you agree that that

it's not asmestin the doctor who's not in the health? If you're really, if you're inpang from the health, from the public health, I don't agree, because if we're mendinging the health, at least we've been in the field of health

before, enthapy, whether to be a doctor, parawat, wiedan, or, on the health of the people. But what I want to garis-bawaheweh, if they're not just that's really practice, like doctor specialists,

or simply they've already S-1, S-2, S-3, but it must have also what, what, yeah, pengotauruant in the bidangment for public health, for the policy, so, not can't be able to beckxed that I should have been for a good job.

Because it's better. But if there's non-doctor, he's got to get-in-atted, how to manage, then make up to structure, which has been able to be able to some of the time before you, to be able to gettened to

to increase the quality of the health. Mastaselon can't be able to be as long as as escelorn is from the people that be filled with the health, so, so, so, not being shifting, not from the casehattan, okay.

Okay, then. Okay, then what's like 15 years ago? You've got, like, the company's already regional. Now, then you've got jabat, and then, succour, stunging, was down 20%, diabetes, is below 20%,

and then what other? Delibateable, what's more? This is, from the policy. But is not it's about what, but efficiency, productivity, and and everything. It's about it, right? Yeah, right.

Mustin' if more more than more than, if you're more than a lot of the health, prestacea in Olympiada, Asian Games, World Cup, or what, has to have, right, right, right, So actually, I'm happy because with the like LPDP, the kids' young Indonesia, now mindset for S2 is a thing that's a lot of not something that's unreachable.

So it's like a whole day, I'm going to S2 where, or to try to S2 where, like that. And it's, it's the potency has more to be more than more than more than being more than I'm being more than I'm going to as long as I'm going to go to the school, that's just enough I'm going to out of the other than we're going to be more than we're going to be in other country, ha ha ha, ha, hi-hi, simply lulled,

but it's more aiming for top school, and at top school, not just as well as but it's just as prominent, too, that's the more than Indonesia can gali again. Now, if we look, spending our for research and development. Yeah, right, ma'am.

Yeah, can, it's about $10 per-one per year per day. If you're maybe $20,000, but the other than the other than Singapore, it's almost $2,000 per one for a month of research and development. So, you're just to stop at the S2a. Or you're maybe, if you've got jabed,

you can make up onergancure to encourage people to take S3 S3. So, the research and development we're more great. Sook-sucur, succors for the pandemic that's in the laboratory in Bekasi. Yeah, right?

What are you going to do about that? If you're going to do, for that? If you're going to be prioritized, because, maybe it's for a long, so on, so, so, so, not we've never in the time same, in this period in this, R&D did naikin,

maybe the result of research that will be that's going to be the periodicists. And it's that's always making them so it's just that's more than to be able to dook on the kids'iott. So, so. So, and it's also, with infrastructure in, yeah, maybe in Indonesia. Because like my friend of Harvard Medical School, who's always in lab, they're a little to

to come to Indo, because they're raced, because they're also advanced for Indo, and then there's infrastructure that's not to put-a-cared. Yeah, it's not. Yeah, device not there. But, right. Right, right. I'm not.

They're like that. They're back again. Yeah, man. Right. Right. So, 2040, 2045, where do you see Indonesia? Indonesia.

If Indonesia, Indonesia, now, I know the country that has potential. But I've been in 2005, it's maximum the potential. From there's been a great potential. And it always remains as a potential. Yeah, it's always as a potential.

Yeah, when it's been actualization. Yeah. Doesn't that make you... Yeah, I'm, yeah, I'm going to get-getan, and I think of one one that,

actually, that's one, but, but, manifestation, what, Manifestasiness, if we have a bonus demography, yeah, sir, there's been many people who are productive,

the number of the use of productive. Now, it's also, maybe, the kind of technology, from the way of the health and it's also, it's justro, we're bonus demography not just for we can't be a big of a manganer, but just to make more people who make more people that's for the other than for the

for the insurance, actually, pa, from the P.js. Oh, yeah. BPJAS, we're very generous, if, if, with the premium $25,000 to $80,000, we can, people, to, people, can get 100-a-juta coverage, that. In one-s-s-that-man-manfought-manfaxeat-bohs really, really,

the way of the other than the top of the but buthurt. But, but people are even to be able to beaubat. But now, even to check up, to spend on to put up, to put up to puskesmas, that's not think of, because there's B. But in one side, there's suffering, like, like, room-sackeet,

the energy, because they have to cover what, what, that's actually to reimburse to B. I'm personally, as well as well as well as well as well not lambat like, okay, if you've got to be able to be able to

be able to, than it's being a burden. So, it's, that's what I'm going to, maybe from financial, it's-itung-itung-in-nation, also has more than, like, premies it's how it's about, so, and what's the cover, it's how it's about. And that's probably so pro-contra, because of the people, Indonesia, can more than middle-lower,

and they're very much more than BPAJS with the with the higher-moura-moura. So, I don't know until when will be a home-sacit and the people who are suffering. Yeah, at the end-ugnugn't is enough, if we're not. If we look, tax ratio our

is about 11%, that's ratio of the pundle of our pdf, but I think, in the long run, 25-town-to-day-the-depth tax ratio we can still If you're on the standard OECD is up 30%.

This ratio of POMPAC to PEDB in the UDGRA, that's at least Now, that's if it's more than than 30%, inshallah, yeah, concern about funding for BPJS or universal health care, it's the must not as problematic now. So, so yeah, infrastructure hard or softening, it's about, Right, right? It's not, right? So, that's in 2004-5,

how we've got to be able tootorkman for education, and for funding, for universal health care, or BPJS, that's just enough. And, this, this, this, this, who are many cheerleaders who, who are going to be economy the number four,

There's the other people who's the other one. What's your view? Are you optimistic? Yeah, optimist, sir. Okay. Is it number one or number four is it's just okay for Indonesia? Aiming, was the most thing is the most of the most of the most. Yeah.

Yeah, like magnet that's on the Mardi-S, only Ibuwanda, right? Right. Tawar-a-a-bye, yeah. Yeah, I think that's pretty impressive. You set the goals high, and you take little steps at a time. Right. Yeah, right kind of kind of a lot of, kind of a bit too small, big steps, to pleset.

Or goal is too big steps to pleset. Yeah. Yeah. What else, Nadirah? What's going to be in the Mastafant Indonesia in the time of 2004-5? Mastafed Indonesia. What other, what other?

Will it be utopian, do you think? How do you think? How do you know? diabetic, stunting, and research and development, funding for BPJS, and and all of the same-and-a-fus so that's not too much

for Mentiary Penedicticent, or Mentiary Kesehatan in 2000-5. So, it's, yeah. So, if, if, the other of the gansansans major-ma-mage-dice, infectious disease, then NCD,

then, and thencreda, then, and thencée is all, and then actually is all right. But, the problem Indonesia is, now we're still being double burden. So we're still, so, so,

so, so, so, so, the infectious disease not self, TBC, not's all, pneumonia, not set. On the same, the ncdn't

the more, the other, and there's – So, so, that's the first, other than we take care.

Right. But the community to be able, we can not know, we mutation virus. Yeah. If we're rewind to 2000, what's, what's, 2003, 2002, October, when we're going to SARS. That's,

it's a mysterious, Augustus 2003, ill. And, and, I'ma'am, as a matter of what's not yet why it's stopped. Yeah, but all right.

And what's actually mutation, from what's in 2002, in 2003. Now, in batas lohika, we can only be thinking, this mutasiness can be able to now. If there's mutation that

more ganas, angupla 24-town from this, one time before target end-game our in 2004-5, for the more than a hundred-year, how much, how much, yeah, it's hard,

if now, if you're going to be, so they're always mutating, but, so jenotip, so far this, so much, but,

but as far phenotip, at least, not, so, impact the other, the other, the back, the same, the amount of,

but it's not, not-mug-the-the-the-vath-a- the fact of the COVID that's always and then, and then justro, mutating, it's just something that's lethal, so, yeah, let's just hope the vaccine it's get-temed and really, really, be impact.

And I don't know how we have always, with presumption, virus is more pinter than research and development. Yeah, right? Yeah. I think you've got to give them the benefit of a doubt. Yeah, right?

And I'm not know, because I see that's now that's just progressive to have quality of health caretas and quality economy and quality of chastraan. Yeah, right? We're not too big think as much as far progressive

now. Yeah, right? Yeah, right. Contracts, quarter two, that's the last, and I don't know quarter three like how, how much, and this maybe it's already impairment that's temporary

that can't to impairment that permanent. Yeah, right? That's, if it's in the sort of, it's to beckyrikin' not to be a badgered because pandemic, it's always be rullang,

yeah? Yeah, never say never. Yeah, right? Spanish flu, 19, 18, that in 100, years, and this is like this is like it's really, yeah.

Yeah, right, ma'am. So, any ideas on controlling or managing? Mugue. Maybe, this is, this is, why I'm going to be thinking. Why don't know if we're having to be a prior to, yeah, sir, actually,

the thing, pandemic like this, not pandemic like this, pandemic that when I was at New York with Patredos, who's the head who's who is always said, that mitigation for pandemic, for preventive, from every country, it's always, they're not ever prepared for the pandemic, as far as economically,

like, it's like, it's not being, have, there, there, and, and, and, and, from the research and development to, like, always have a device that's enough to to take vaccine and other, and maybe that's awareness that because

because pandemic this is also more than the other than the country is real and maybe will be able to be able, so they can be more than from the way and from R&D to be up again, but if we're talking about infection that like COVID-like this,

it's always hard for a country not not-mallame, you know, I'm talking about non-communicable disease that's more to be used like people who are

out there's not like TBC when I was in Japan first, I was in Klaus in there, I'm, I'm,

then, after that patient's, I feel like this TBC, de, in Japan. Because that diagnosis that's common really if I

practice in RIMA, I'm doing TBC, then, people are people getawed all,

doctor, yeah, because yeah, yeah, oh, I remember. So I'm sorry, like, oh, in India, I'ma, every day, there's a lot of people TBC, past, so. So, it's like, like, it's like, I'm going to beawebawasan my,

so, like, you know, from the extent of the same-asd-M-ness, I mean, I've, like, the country that's like, but, but, it's reality, to, it's like, like in Africa,

the other and the other than the other than the other than the other than I'm going to be able to be able to be able to be. Amen, I'm going to say, I'm going to try to compare on what I'm going to do with what in Swedenia, herd immunity, than in, again,

where that social distancing that's very tight. Do you believe in heart immunity or you believe in physical or social distancing? I believe more in social distancing. Actually, heart immunity, it's just, it's like, like, selection of the alam and it's not ideal for people, by the way we're rela to make the method of heart immunity, it's not just like to have people our own people

that's a lot of, yeah, to selects just as a lot of, and it's not ideal and not ethical, so. So, I'm more to socialism. Now, if I look, this, we've got got gayser from activities that communal to non-comunal, activity that offline, online. I'm saying, for the PENCACA-D-D-D-PAN, if, Amid, am I, amy,

the other, can, pandemic, there are, there are some of the day-a-day-day-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a. Yeah, ma'a. we can even more than offline. Well, if I'm not that's one or two that we can do as a preventive measure. In the event, that's going to be a pandemic

that's more gawatt. What do you think? Because, because, because we're for the way of the salamans, it's rinked up to prevent COVID-in-it-it-it-in-it-natured. Nanty, if COVID-nap-nepin-in-in-law, it's to prevent

all the infectious disease that might beware. Like, for flu-biasa-pun, can be prevented. TBS, same pneumonia. Basically, whatever, can be more better, it's, I'm more than,

I also I'm also a founder of stenting, that's one thousand days. So, he, that, amazed, with the other people's being more than more than to clean, and then-an-and-and-and-a-ar-a-ar-a-ar-dikali, that's not just to prevent COVID, but, actually, the other for years-torn-tuning

in there, it's been taken to happen when COVID, it's actually, because of the people's the because of the people that's the way of the other, and what I'm trying to say is that we're not just to take COVID, with the real life, basically, and to cedehaping whatever the other. So, no, it's for we're taping,

to-trucesan to the depot-to-de-pani. Yeah. Thank you so much, Nadira. Thank you, Ma, Gita. Okay, ma, thank you. Thank you. I amyra Ava. That's about about about

from playing flute. Succa, with mathematics, solat in the back down the titha, to be the people to be the people to be the people.

Thank you. This is NG.